视网膜静脉阻塞-话题@MedSci

#视网膜静脉阻塞#

10篇内容 | 571人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1581625, encodeId=95fc1581625a3, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系, objectType=article, longId=214922, objectId=a0cf214922cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0cf214922cb, replyNumber=0, likeNumber=19, createdTime=2021-07-29, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0cf214922cb, moduleTitle=Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0cf214922cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581624, encodeId=08701581624f3, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, objectType=article, longId=187876, objectId=f10618e87660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f10618e87660, replyNumber=0, likeNumber=27, createdTime=2020-02-13, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10618e87660, moduleTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f10618e87660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581623, encodeId=9202158162397, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=2019 AAO临床指南：视网膜静脉阻塞, objectType=article, longId=183150, objectId=e8d118315034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d118315034, replyNumber=0, likeNumber=0, createdTime=2019-11-19, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d118315034, moduleTitle=2019 AAO临床指南：视网膜静脉阻塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8d118315034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581622, encodeId=ea25158162288, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=J Hypertens：高血压和多种心血管危险因素会增加视网膜静脉阻塞的风险, objectType=article, longId=165523, objectId=0ad3165523f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad3165523f3, replyNumber=0, likeNumber=31, createdTime=2019-05-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad3165523f3, moduleTitle=J Hypertens：高血压和多种心血管危险因素会增加视网膜静脉阻塞的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ad3165523f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581621, encodeId=75931581621a2, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制, objectType=article, longId=133576, objectId=db5f1335e647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5f1335e647, replyNumber=0, likeNumber=29, createdTime=2018-03-28, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5f1335e647, moduleTitle=Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db5f1335e647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581620, encodeId=8ffa1581620d5, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=PLoS One：二甲双胍对糖尿病视网膜静脉阻塞具有保护作用！, objectType=article, longId=120893, objectId=53a912089360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53a912089360, replyNumber=0, likeNumber=33, createdTime=2017-11-22, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53a912089360, moduleTitle=PLoS One：二甲双胍对糖尿病视网膜静脉阻塞具有保护作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53a912089360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581619, encodeId=a8c3158161947, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=Ophthalmology.：美国眼科学会的一项关于与分支视网膜静脉阻塞相关的黄斑水肿的疗法的报告, objectType=article, longId=102365, objectId=342b10236537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=342b10236537, replyNumber=0, likeNumber=40, createdTime=2017-06-20, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=342b10236537, moduleTitle=Ophthalmology.：美国眼科学会的一项关于与分支视网膜静脉阻塞相关的黄斑水肿的疗法的报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=342b10236537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581618, encodeId=080715816189a, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=BMJ：继发于西地那非治疗后的视网膜静脉阻塞 -案例报道, objectType=article, longId=93667, objectId=116f9366e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=116f9366e46, replyNumber=0, likeNumber=27, createdTime=2017-03-29, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=116f9366e46, moduleTitle=BMJ：继发于西地那非治疗后的视网膜静脉阻塞 -案例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=116f9366e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581617, encodeId=36c6158161edc, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=Neurology: 视网膜静脉阻塞患者更易发生缺血性卒中, objectType=article, longId=57135, objectId=69645e135ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69645e135ac, replyNumber=0, likeNumber=31, createdTime=2015-10-14, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69645e135ac, moduleTitle=Neurology: 视网膜静脉阻塞患者更易发生缺血性卒中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69645e135ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581616, encodeId=6ad21581616de, content=<a href='/topic/show?id=0f8e90830d9' target=_blank style='color:#2F92EE;'>#视网膜静脉阻塞#</a>, objectTitle=拜耳眼科药物Eylea视网膜静脉阻塞继发黄斑水肿（ME-RVO）新适应症获日本批准, objectType=article, longId=52572, objectId=bff4525e2dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bff4525e2dc, replyNumber=0, likeNumber=22, createdTime=2015-07-01, rootId=0, userName=passed water, userId=ca5e16842121, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bff4525e2dc, moduleTitle=拜耳眼科药物Eylea视网膜静脉阻塞继发黄斑水肿（ME-RVO）新适应症获日本批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bff4525e2dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

视网膜静脉阻塞

2020-05-29

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

Diabetes Care：2型糖尿病患者SGLT2抑制剂与视网膜静脉阻塞风险的关系

2021-07-29

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果

2020-02-13

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

2019 AAO临床指南：视网膜静脉阻塞

2019-11-19

爆笑小医 (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

J Hypertens：高血压和多种心血管危险因素会增加视网膜静脉阻塞的风险

2019-05-08

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

Jpn J Ophthalmol：黄斑水肿与视网膜静脉阻塞相关的视力丧失机制

2018-03-28

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

PLoS One：二甲双胍对糖尿病视网膜静脉阻塞具有保护作用！

2017-11-22

docwu2019 (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

Ophthalmology.：美国眼科学会的一项关于与分支视网膜静脉阻塞相关的黄斑水肿的疗法的报告

2017-06-20

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

BMJ：继发于西地那非治疗后的视网膜静脉阻塞 -案例报道

2017-03-29

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

Neurology: 视网膜静脉阻塞患者更易发生缺血性卒中

2015-10-14

passed water (审核中...)

前往app查看评论内容

#视网膜静脉阻塞#

拜耳眼科药物Eylea视网膜静脉阻塞继发黄斑水肿（ME-RVO）新适应症获日本批准

2015-07-01

科室
- - 订阅+
  - 更多科室
工具
服务